Binding of anti-prion agents to glycosaminoglycans: Evidence from electronic absorption and circular dichroism spectroscopy

Biochemical and Biophysical Research Communications

Volumn 346, Issue 4, 2006, Pages 1267-1274

  Zsila, Ferenc ^a   Gedeon, Gábor ^b  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b INSTITUTE FOR ADVANCED STUDY   (Hungary)

Author keywords

Amyloid; Chlorpromazine; Chondroitin 6 sulfate; Circular dichroism spectroscopy; Glycosaminoglycans; Heparin; Hypochromism; Prion; Quinacrine

Indexed keywords

ACRIDINE; AMYLOID; CHLORPROMAZINE; CHONDROITIN 6 SULFATE; GLYCOSAMINOGLYCAN; HEPARIN; MEPACRINE; PHENOTHIAZINE DERIVATIVE; PRIMAQUINE; QUINIDINE; QUINOLINE; TACRINE;

ABSORPTION SPECTROSCOPY; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; DENSITY; ELECTRICITY; IONIC STRENGTH; PRIORITY JOURNAL; PROTEIN INTERACTION; TITRIMETRY; ULTRAVIOLET SPECTROSCOPY;

ABSORPTION; CHONDROITIN SULFATES; CIRCULAR DICHROISM; GLYCOSAMINOGLYCANS; HEPARIN; PRIONS; QUINACRINE;

EID: 33745333934     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.033     Document Type: Article

References (29)

1. Rabenstein D.L. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 19 (2002) 312-331
2. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., and Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 13 (2003) 612-620
3. Jones L.S., Yazzie B., and Middaugh C.R. Polyanions and the proteome. Mol. Cell. Proteomics 3 (2004) 746-769
4. Diaz-Nido J., Wandosell F., and Avila J. Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23 (2002) 1323-1332
5. Fraser P.E., Darabie A.A., and McLaurin J.A. Amyloid-β interactions with chondroitin sulfate-derived monosaccharides and disaccharides, implications for drug development. J. Biol. Chem. 276 (2001) 6412-6419
6. Castillo G.M., Lukito W., Wight T.N., and Snow A.D. The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation. J. Neurochem. 72 (1999) 1681-1687
7. Klajnert B., Cortijo-Arellano M., Bryszewska M., and Cladera J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem. Biophys. Res. Commun. 339 (2006) 577-582
8. Sc incorporation to cells requires endogenous glycosaminoglycan expression. J. Biol. Chem. 280 (2005) 17057-17061
9. Pan T., Wong B.S., Liu T., Li R., Petersen R.B., and Sy M.S. Cell-surface prion protein interacts with glycosaminoglycans. Biochem. J. 368 (2002) 81-90
10. Korth C., May B.C., Cohen F.E., and Prusiner S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98 (2001) 9836-9841
11. Doh-Ura K., Iwaki T., and Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74 (2000) 4894-4897
12. Murakami-Kubo I., Doh-Ura K., Ishikawa K., Kawatake S., Sasaki K., Kira J., Ohta S., and Iwaki T. Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies. J. Virol. 78 (2004) 1281-1288
13. Barret A., Tagliavini F., Forloni G., Bate C., Salmona M., Colombo L., De Luigi A., Limido L., Suardi S., Rossi G., Auvre F., Adjou K.T., Sales N., Williams A., Lasmezas C., and Deslys J.P. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77 (2003) 8462-8469
14. Zhang S., Zhao F., Li N., Li K., and Tong S. Spectroscopic studies on the spontaneous assembly of phenosafranin on glycosaminoglycans templates. Spectrochim. Acta A Mol. Biomol. Spectrosc. 58 (2002) 2613-2619
15. Jiao Q.C., Liu Q., Sun C., and He H. Investigation on the binding site in heparin by spectrophotometry. Talanta 48 (1999) 1095-1101
16. Chen Q., Li X.L., Liu Q., Jiao Q.C., Cao W.G., and Wan H. Investigating the binding interaction of azur A with hyaluronic acid via spectrophotometry and its analytical application. Anal. Bioanal. Chem. 328 (2005) 1513-1519
17. Templeton D.M. General occurrence of isosbestic points in the metachromatic dye complexes of sulphated glycosaminoglycans. Int. J. Biol. Macromol. 10 (1988) 131-136
18. Salter M.K., Rippon W.B., and Abrahamson E.W. Spectroscopic properties of complexes of acridine orange with glycosaminoglycans. I. Soluble complexes. Biopolymers 15 (1976) 1213-1227
19. Heyn M.P. Dependence of exciton circular dichroism amplitudes on oscillator strength. J. Phys. Chem. 79 (1975) 2424-2426
20. Racchi M., Mazzucchelli M., Porrello E., Lanni C., and Govoni S. Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol. Res. 50 (2004) 441-451
21. Stone A.L., and Moss H. Anomalous rotatory dispersion of metachromatic mucopolysaccharide-dye complexes. II. Heparin-methylene blue complexes at acidic pH. Biochim. Biophys Acta 136 (1967) 56-66
22. Taniguchi S., Suzuki N., Masuda M., Hisanaga S., Iwatsubo T., Goedert M., and Hasegawa M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem. 280 (2005) 7614-7623
23. Kasha M., Rawls H.R., and Ashraf El-Bayoumi M. Exciton model in molecular spectroscopy. Pure Appl. Chem. 11 (1965) 371-392
24. Brunden K.R., Richter-Cook N.J., Chaturvedi N., and Frederickson R.C. pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61 (1993) 2147-2154
25. Fischer J., Lullmann H., and Lullmann-Rauch R. Drug-induced lysosomal storage of sulphated glycosaminoglycans. Gen. Pharmacol. 27 (1996) 1317-1324
26. Lullmann-Rauch R., Pods R., and von Witzendorff B. The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo. Toxicology 110 (1996) 27-37
27. Bispinck F., Fischer J., Lullmann-Rauch R., and von Witzendorff B. Lysosomal glycosaminoglycan storage as induced by dicationic amphiphilic drugs: investigation into the mechanisms underlying the slow reversibility. Toxicology 128 (1998) 91-100
28. Mayer-Sonnenfeld T., Zeigler M., Halimi M., Dayan Y., Herzog C., Lasmezas C.I., and Gabizon R. The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol. Dis. 20 (2005) 738-743
29. Kawarabayashi T., Igeta Y., Sato M., Sasaki A., Matsubara E., Kanai M., Tomidokoro Y., Ishiguro K., Okamoto K., Hirai S., and Shoji M. Lysosomal generation of amyloid β protein species in transgenic mice. Brain Res. 765 (1997) 343-348